Children with asthma who visited an allergy specialist were 21% less likely ... has completed its phase 2a trial of TDM-180935 for the treatment of atopic dermatitis, demonstrating the efficacy ...

While the exact cause of asthma is unknown, certain genetic factors can increase the risk of developing the disease.

The global allergy immunotherapy market is expected to grow from USD 1.74 billion in 2023 to USD 4.07 billion by 2033, at a ...

Yes, people have died from asthma, including children and adults. Learn about socioeconomic variables and comorbid factors in ...

Impacting millions of children in the U.S. alone, asthma can be particularly problematic to diagnose with specificity — ...

New grant funding awarded to a research collaboration from the Brigham and Women’s Hospital and the Boston-based Wyss ...

The global aspergillosis treatment market, valued at USD 3,055.88 million in 2022, is poised for robust growth in the coming ...

Presence of eosinophilic inflammation in the airway predicted asthma development among children aged 5 years and younger with treatment-refractory ... division of asthma, allergy and immunology ...

Marianne Baastrup Soendergaard, Department of Respiratory Medicine, Copenhagen University Hospital–Bispebjerg, Copenhagen, ...

A Safer Treatment Path for High-Risk Children ... and appear to cause the most harm in men who develop asthma in later ... Toddlers Allergic to Peanuts: Study Shows How Sublingual Immunotherapy ...

Nov. 27, 2024 — A recent trial finds an injection given during some asthma and COPD attacks is more effective than the current treatment ... Risks for Those With Allergies and Asthma Oct ...